Weight Management for Adolescents With IDD

NCT ID: NCT02561754

Last Updated: 2023-02-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2021-05-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rates of obesity and obesity related chronic health conditions are higher in adolescents with Intellectual and Developmental Disabilities (IDD) than those in the general population. Many of the negative health consequences observed in obese adults are already present in obese adolescents with IDD.

This study is a 3 group randomized trial to evaluate the intervention delivery system and type of reduced energy diet. The investigators will randomize 123 overweight/obese adolescents with mild to moderate IDD to one of 3 groups for an 18 month trial (6 month weight loss; 12 month weight maintenance):

group 1) Face-To-Face/CD

group 2) Technology delivery/CD

group 3) Technology delivery/eSLD.

All participants will receive a progressive program of physical activity. Participants on the CD diet will be asked to consume a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet. Participants on the eSLD will consume pre-packaged portion controlled meals with the addition of 5 fruits and vegetables per day.

FTF will meet with a health educator and will track progress using pen and paper records for both physical activity and diet. TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Developmental Disabilities Weight Loss Body Weight Down Syndrome Body Weight Changes Intellectual Disability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Face-To-Face/CD

Delivery: Face-to-face Diet: Conventional diet

Group Type ACTIVE_COMPARATOR

Conventional Diet (CD)

Intervention Type DIETARY_SUPPLEMENT

CD is a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet.

Face-to-face (FTF)

Intervention Type BEHAVIORAL

FTF will meet with a health educator in person and will track progress using pen and paper records for both physical activity and diet.

Technology delivery/CD

Delivery: Technology Diet: Conventional diet

Group Type EXPERIMENTAL

Conventional Diet (CD)

Intervention Type DIETARY_SUPPLEMENT

CD is a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet.

Technology (TECH)

Intervention Type BEHAVIORAL

TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

iPad with FaceTime

Intervention Type OTHER

TECH groups will receive the intervention using an iPad with the FaceTimeTM to the intervention field.

Technology delivery/eSLD

Delivery: Technology Diet: enhanced Stop Light Diet

Group Type EXPERIMENTAL

Enhanced Stop Light Diet (eSLD)

Intervention Type DIETARY_SUPPLEMENT

eSDL includes reduced energy portion controlled meals for 6 months, encouraged consumption of lower energy shakes and 35 fruits and vegetables per week.

Technology (TECH)

Intervention Type BEHAVIORAL

TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

iPad with FaceTime

Intervention Type OTHER

TECH groups will receive the intervention using an iPad with the FaceTimeTM to the intervention field.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enhanced Stop Light Diet (eSLD)

eSDL includes reduced energy portion controlled meals for 6 months, encouraged consumption of lower energy shakes and 35 fruits and vegetables per week.

Intervention Type DIETARY_SUPPLEMENT

Conventional Diet (CD)

CD is a nutritionally balanced, reduced energy, high volume, lower fat ( fat=20-30% energy) diet.

Intervention Type DIETARY_SUPPLEMENT

Face-to-face (FTF)

FTF will meet with a health educator in person and will track progress using pen and paper records for both physical activity and diet.

Intervention Type BEHAVIORAL

Technology (TECH)

TECH groups will receive the intervention using an iPad with the FaceTimeTM application for video meetings with a health educator and will track progress using the Lose it! application for both physical activity and diet.

Intervention Type BEHAVIORAL

iPad with FaceTime

TECH groups will receive the intervention using an iPad with the FaceTimeTM to the intervention field.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 13-21 yrs
* Mild (IQ of 74-50) or moderate (IQ 40-49) IDD,
* Of sufficient functional ability to understand directions, communicate preferences (e.g. foods), wants (e.g. more to eat/drink), and needs (e.g. assistance with food preparation) through spoken language.
* Overweight or obese (BMI ≥ 85th%ile on CDC growth charts, or waist circumference to height ratio \> 0.5
* Living at home with a parent or guardian.
* Internet access in the home.
* No plans to relocate outside the study area over the next 18 mos
* Physician consent for PA and diet.

Exclusion Criteria

* Insulin dependent diabetes
* Participation in a weight management program involving diet and PA in the past 6 mos
* Eating disorders, serious food allergies, consuming special diets, aversion to common foods,
* Diagnosis of Prader-Willi Syndrome
* Currently pregnant, planning on/becoming pregnant during the study.
* Unable to participate in moderate to vigorous PA.
Minimum Eligible Age

13 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role collaborator

University of Kansas Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph E Donnelly, EdD

Role: PRINCIPAL_INVESTIGATOR

University of Kansas Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Energy Balance Lab, The University of Kansas

Lawrence, Kansas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Bodde AE, White DA, Forseth B, Hastert M, Washburn R, Donnelly J, Sullivan D, Ptomey LT. Parent factors associated with BMI, diet, and physical activity of adolescents with intellectual and developmental disabilities. Disabil Health J. 2023 Oct;16(4):101507. doi: 10.1016/j.dhjo.2023.101507. Epub 2023 Jul 7.

Reference Type DERIVED
PMID: 37487764 (View on PubMed)

Bodde AE, Helsel BC, Hastert M, Suire KB, Washburn RA, Donnelly JE, Ptomey LT. The prevalence of obesity and lifestyle behaviors of parents of youth with intellectual and developmental disabilities. Disabil Health J. 2023 Jul;16(3):101430. doi: 10.1016/j.dhjo.2022.101430. Epub 2022 Dec 14.

Reference Type DERIVED
PMID: 36604240 (View on PubMed)

Ptomey LT, Lee J, White DA, Helsel BC, Washburn RA, Donnelly JE. Changes in physical activity across a 6-month weight loss intervention in adolescents with intellectual and developmental disabilities. J Intellect Disabil Res. 2022 Jun;66(6):545-557. doi: 10.1111/jir.12909. Epub 2021 Dec 16.

Reference Type DERIVED
PMID: 34915594 (View on PubMed)

Ptomey LT, Washburn RA, Goetz JR, Sullivan DK, Gibson CA, Mayo MS, Krebill R, Gorczyca AM, Montgomery RN, Honas JJ, Helsel BC, Donnelly JE. Weight Loss Interventions for Adolescents With Intellectual Disabilities: An RCT. Pediatrics. 2021 Sep;148(3):e2021050261. doi: 10.1542/peds.2021-050261. Epub 2021 Aug 19.

Reference Type DERIVED
PMID: 34413247 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R01HD079642

Identifier Type: NIH

Identifier Source: secondary_id

View Link

STUDY00001857

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Meal Replacement Study
NCT02355041 WITHDRAWN PHASE3